Dorzolamide Hydrochloride And Timolol Maleate Solution/ Drops
Product Images NDC 68083-490

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Dorzolamide Hydrochloride And Timolol Maleate (NDC 68083-490). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bottle-label (Bottle Label)

Bottle-label (Bottle Label)
Label for Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution, USP 2%/0.5%, 10 mL, by Gland Pharma Limited. The label includes the NDC 68083-490-01 and states it is for topical application in the eye. Storage instructions specify 20°C to 25°C, and dosing reference directs to the package insert. Space for lot and expiration dates is provided.*
FDA Label Image

Carton-label (Carton Label)

Carton-label (Carton Label)
Packaging label for Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution, USP 2%/0.5%, 10 mL topical eye drops. The label includes registration number NDC 68083-490-01 and states Rx only. It lists storage instructions, inactive ingredients, preservative content, and manufacturer details for Gland Pharma Limited, Hyderabad, India. The label features an image of an eye and a barcode for scanning.*
FDA Label Image

Dorzolamide (Structure)

Dorzolamide (Structure)
Chemical structure diagram of Dorzolamide Hydrochloride, one of the active ingredients in the ophthalmic solution Dorzolamide Hydrochloride and Timolol Maleate by Gland Pharma Limited.*
FDA Label Image

Figure A (Figure A)

Figure A (Figure A)
An instructional diagram of an ophthalmic solution bottle showing labeled parts: cap, tamper evident ring, and bottle. The illustration is likely for Dorzolamide Hydrochloride and Timolol Maleate ophthalmic solution drops, highlighting the bottle components for proper handling.*
FDA Label Image

Figure B (Figure B)

Figure B (Figure B)
An instructional illustration labeled 'Figure B' showing a dropper bottle for ophthalmic solution with the cap partially removed and rotated to indicate how to open or close the bottle. The image depicts the threaded neck of the bottle and the dropper tip.*
FDA Label Image

Figure C (Figure C)

Figure C (Figure C)
An instructional diagram labeled 'Figure C' showing a person pulling down their lower eyelid with one hand while applying an eye drop into the eye, demonstrating proper ophthalmic solution administration technique.*
FDA Label Image

Figure D (Figure D)

Figure D (Figure D)
An instructional illustration showing proper administration of eye drops. The left panel depicts a hand holding a dropper bottle above an open eye while the other hand gently pulls down the lower eyelid. The right panel zooms in on a drop leaving the bottle, about to fall into the eye.*
FDA Label Image

Timolol (Structure)

Timolol (Structure)
Chemical structure diagram showing the molecular structures of Dorzolamide Hydrochloride and Timolol Maleate, the active ingredients in the ophthalmic solution Dorzolamide Hydrochloride and Timolol Maleate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.